Ken Griffin Beyond Air, Inc. Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Beyond Air, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 49,600 shares of XAIR stock, worth $156,736. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,600
Previous 37,100
33.69%
Holding current value
$156,736
Previous $10,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding XAIR
# of Institutions
43Shares Held
11.3MCall Options Held
49.6KPut Options Held
0-
Balyasny Asset Management LLC Chicago, IL3.33MShares$10.5 Million0.0% of portfolio
-
Lasry Marc New York, NY1.64MShares$5.18 Million9.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.45MShares$4.59 Million0.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY937KShares$2.96 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA838KShares$2.65 Million0.0% of portfolio
About Beyond Air, Inc.
- Ticker XAIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 29,888,000
- Market Cap $94.4M
- Description
- Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...